Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients

Sponsor
University of Michigan (Other)
Overall Status
Completed
CT.gov ID
NCT02444195
Collaborator
(none)
130
1
2
13
10

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the effectiveness of self-administered perioperative guided imagery to reduce perioperative distress in gynecologic oncology patients undergoing surgical management for a presumed cancer diagnosis.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Guided Imagery With Audio Media
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
130 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Self-Administered Guided Imagery in the Perioperative Period to Reduce Postoperative Distress in Gynecologic Oncology Patients: A Randomized Control Trial
Study Start Date :
Apr 1, 2015
Actual Primary Completion Date :
May 1, 2016
Actual Study Completion Date :
May 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Guided Imagery

Guided Imagery With Audio Media

Behavioral: Guided Imagery With Audio Media
Subjects assigned to the experimental arm will be asked to participate in meditation daily using the audio media provided for the 7 days prior to surgery, in the preoperative holding area, for the 7 days following surgery, and are encouraged to engage in affirmations module use at least weekly in the 6-8 week postoperative period.

No Intervention: Routine Postoperative Care

Subjects will receive routine pre-operative, intra-operative, post-operative, chemotherapy, and radiation care as dictated by pathologic diagnosis.

Outcome Measures

Primary Outcome Measures

  1. Level of distress in the immediate postoperative period, measured by the numeric rating scale/ National Comprehensive Cancer Network (NCCN) Distress Thermometer screening instrument. [postoperative day 1]

  2. Level of distress in the delayed postoperative period, measured by the numeric rating scale/ National Comprehensive Cancer Network (NCCN) Distress Thermometer screening instrument. [6-8 week postoperative exam]

Secondary Outcome Measures

  1. Level of distress, measured by questionnaire using the Hospital Anxiety and Depression Scale-total (HADS-T). [postoperative day 1 and 6-8 week postoperative exam]

  2. Level of anxiety and depressions, measured by questionnaire using the Hospital Anxiety and Depression Scale subscale for anxiety (HADS-A) and depression (HADS-D). [postoperative day 1 and 6-8 week postoperative exam]

  3. Level of pain, measured by a 7-item questionnaire using a Likert numerical rating scale for pain [postoperative day 1 and 6-8 week postoperative exam]

  4. Perioperative analgesic use, measured by patient-completed usage log and hospital medical record. [postoperative day 1 and 6-8 week postoperative exam]

  5. Patient satisfaction regarding in hospital perioperative care, measured by a questionnaire adapted from the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey. [postoperative day 1 and 6-8 week postoperative exam]

  6. Effect of perioperative guided imagery on health care compliance, measured by the General Adherence Scale (GAS) survey. [6-8 week postoperative visit]

  7. Effect of perioperative guided imagery on health care related locus of control, measured by the Multidimensional Health Locus of Control-form A (MHLC-A) questionnaire. [postoperative day 1 and 6-8 week postoperative exam]

  8. The effect of perioperative guided imagery on hope, measured by the Adult Hope Scale (AHS) questionnaire. [postoperative day 1 and 6-8 week postoperative exam]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Undergoing surgical management for a suspected diagnosis of Gynecologic Malignancy (Endometrial, Ovarian, Vulvar, Vaginal, Primary Peritoneal, Fallopian Tube)

  • Age 18 or greater

  • Receiving care at University of Michigan Comprehensive Cancer Center Gynecologic Oncology Clinic or at St. Joseph Mercy Hospital, Alexander Cancer Care Center

  • Able to understand and read English

  • Eastern Cooperative Oncology Group (ECOG) performance status of 0-2

  • Patients must have working telephone, mobile or land line

Exclusion Criteria:
  • Severe hearing impairment that limits the ability to use audio-based guided imagery modules

  • Current documented alcohol abuse or illicit drug substance abuse

  • Planned outpatient surgery

  • Patients currently participating in a meditation practice for more than 1 hour per week prior to preoperative visit.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Michigan Cancer Center Ann Arbor Michigan United States 48109

Sponsors and Collaborators

  • University of Michigan

Investigators

  • Principal Investigator: Brandy Michaels, MD, University of Michigan
  • Principal Investigator: J. Rebecca Liu, MD, University of Michigan

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Brandy Michaels, Gynecologic Oncology Fellow, University of Michigan
ClinicalTrials.gov Identifier:
NCT02444195
Other Study ID Numbers:
  • HUM00095520
First Posted:
May 14, 2015
Last Update Posted:
Mar 20, 2017
Last Verified:
Mar 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Brandy Michaels, Gynecologic Oncology Fellow, University of Michigan
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 20, 2017